{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:48:17Z","timestamp":1788194897645,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:00:00Z","timestamp":1573689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:00:00Z","timestamp":1573689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This study was supported by Korean Cancer Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Many patients with plasma cell disorders suffer from peripheral neuropathy, but differential diagnosis with chronic inflammatory demyelinating polyneuropathy (CIDP) is difficult. We aimed to (1) identify factors useful for differential diagnosis between peripheral neuropathy associated with plasma cell disorders versus CIDP and (2) determine whether neuropathy presentations and severity varied across the spectrum of different plasma cell disorders. A retrospective chart review of 18 monoclonal gammopathy of unknown significance (MGUS) patients, 15 POEMS syndrome patients and 34 CIDP patients between January 2005 and December 2016 was conducted. The peripheral neuropathy associated with plasma cell disorders seemed to be more sensory oriented compared to CIDP. MGUS patients were significantly older than CIDP patients (median age 70 vs. 59, respectively, <jats:italic>p<\/jats:italic>\u2009=\u20090.027). POEMS syndrome patients showed significantly higher platelet count at the time of neuropathy presentation compared to CIDP (<jats:italic>p<\/jats:italic>\u2009=\u20090.028). Lambda type MGUS patients were associated with less severe symptoms compared to POEMS syndrome patients despite harboring lambda monoclonal gammopathy as a common denominator. Kappa type MGUS patients showed predominantly axonal type neuropathy compared to its counterpart and POEMS syndrome. Careful inspection of clinical profiles and symptoms of patients presenting with neuropathy can help to discriminate those with underlying plasma cell disorders. The phenotype of neuropathy, platelet count and age at presentation seem to be the most useful indicators.<\/jats:p>","DOI":"10.1038\/s41598-019-53289-w","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T11:03:11Z","timestamp":1573729391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Distinctive patterns of peripheral neuropathy across the spectrum of plasma cell disorders"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1780-5553","authenticated-orcid":false,"given":"Ja Min","family":"Byun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3588-274X","authenticated-orcid":false,"given":"Young Nam","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngil","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Soo","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Joon","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,14]]},"reference":[{"key":"53289_CR1","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar, S. V. et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15, 538\u2013548 (2014).","journal-title":"Lancet Oncol"},{"key":"53289_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s11910-011-0237-4","volume":"12","author":"S Ramchandren","year":"2012","unstructured":"Ramchandren, S. & Lewis, R. A. An update on monoclonal gammopathy and neuropathy. Curr Neurol Neurosci Rep 12, 102\u2013110 (2012).","journal-title":"Curr Neurol Neurosci Rep"},{"key":"53289_CR3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/WCO.0b013e32832fd563","volume":"22","author":"S Ramchandren","year":"2009","unstructured":"Ramchandren, S. & Lewis, R. A. Monoclonal gammopathy and neuropathy. Curr Opin Neurol 22, 480\u2013485 (2009).","journal-title":"Curr Opin Neurol"},{"key":"53289_CR4","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1056\/NEJM199212313272705","volume":"327","author":"GD Miralles","year":"1992","unstructured":"Miralles, G. D., O\u2019Fallon, J. R. & Talley, N. J. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome. N Engl J Med 327, 1919\u20131923 (1992).","journal-title":"N Engl J Med"},{"key":"53289_CR5","first-page":"190","volume":"1","author":"JJ Kelly","year":"2004","unstructured":"Kelly, J. J. The evaluation of peripheral neuropathy. Part II: Identifying common clinical syndromes. Rev Neurol Dis 1, 190\u2013201 (2004).","journal-title":"Rev Neurol Dis"},{"key":"53289_CR6","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1080\/10428190903111922","volume":"50","author":"SA Zivkovic","year":"2009","unstructured":"Zivkovic, S. A., Lacomis, D. & Lentzsch, S. Paraproteinemic neuropathy. Leuk Lymphoma 50, 1422\u20131433 (2009).","journal-title":"Leuk Lymphoma"},{"key":"53289_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mus.24471","volume":"51","author":"D Raheja","year":"2015","unstructured":"Raheja, D., Specht, C. & Simmons, Z. Paraproteinemic neuropathies. Muscle Nerve 51, 1\u201313 (2015).","journal-title":"Muscle Nerve"},{"key":"53289_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0532-4","volume":"16","author":"RA Rison","year":"2016","unstructured":"Rison, R. A. & Beydoun, S. R. Paraproteinemic neuropathy: a practical review. BMC Neurol 16, 13 (2016).","journal-title":"BMC Neurol"},{"key":"53289_CR9","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle, R. A. et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 354, 1362\u20131369 (2006).","journal-title":"N Engl J Med"},{"key":"53289_CR10","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1212\/WNL.31.11.1480","volume":"31","author":"JJ Kelly","year":"1981","unstructured":"Kelly, J. J. et al. Prevalence of monoclonal protein in peripheral neuropathy. Neurology 31, 1480\u20131483 (1981).","journal-title":"Neurology"},{"key":"53289_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/leu.2008.291","volume":"23","author":"RA Kyle","year":"2009","unstructured":"Kyle, R. A. & Rajkumar, S. V. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia 23, 3\u20139 (2009).","journal-title":"Leukemia"},{"key":"53289_CR12","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"PY Van den Bergh","year":"2010","unstructured":"Van den Bergh, P. Y. et al. European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision. Eur J Neurol 17, 356\u2013363 (2010).","journal-title":"Eur J Neurol"},{"key":"53289_CR13","doi-asserted-by":"crossref","unstructured":"Joint Task Force of the EFNS and, the PNS. European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-First Revision. J Peripher Nerv Syst 15, 1\u20139 (2010).","DOI":"10.1111\/j.1529-8027.2010.00245.x"},{"key":"53289_CR14","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jnnp-2011-301706","volume":"83","author":"S Nasu","year":"2012","unstructured":"Nasu, S. et al. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 83, 476\u2013479 (2012).","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"53289_CR15","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/mus.24768","volume":"52","author":"E Naddaf","year":"2015","unstructured":"Naddaf, E. et al. Thrombocytosis distinguishes POEMS syndrome from chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 52, 658\u2013659 (2015).","journal-title":"Muscle Nerve"},{"key":"53289_CR16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1600-0404.1992.tb06033.x","volume":"85","author":"E Nobile-Orazio","year":"1992","unstructured":"Nobile-Orazio, E. et al. Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies. Acta Neurol Scand 85, 383\u2013390 (1992).","journal-title":"Acta Neurol Scand"},{"key":"53289_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/BF00319857","volume":"238","author":"KB Yeung","year":"1991","unstructured":"Yeung, K. B. et al. The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings. J Neurol 238, 383\u2013391 (1991).","journal-title":"J Neurol"},{"key":"53289_CR18","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.mayocp.2017.02.003","volume":"92","author":"HM Chaudhry","year":"2017","unstructured":"Chaudhry, H. M., Mauermann, M. L. & Rajkumar, S. V. Monoclonal Gammopathy-Associated Peripheral Neuropathy: Diagnosis and Management. Mayo Clin Proc 92, 838\u2013850 (2017).","journal-title":"Mayo Clin Proc"},{"key":"53289_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0022-510X(99)00049-0","volume":"164","author":"A Di Troia","year":"1991","unstructured":"Di Troia, A. et al. Clinical features and anti-neural reactivity in neuropathy associated with IgG monoclonal gammopathy of undetermined significance. J Neurol Sci 164, 64\u201371 (1991).","journal-title":"J Neurol Sci"},{"key":"53289_CR20","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00277-014-2294-7","volume":"94","author":"G Talamo","year":"2015","unstructured":"Talamo, G. et al. IgM MGUS associated with anti-MAG neuopathy: a single institution experience. Ann Hematol 94, 1011\u20131016 (2015).","journal-title":"Ann Hematol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53289-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53289-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53289-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T15:55:24Z","timestamp":1671292524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53289-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,14]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["53289"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-53289-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,14]]},"assertion":[{"value":"19 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16769"}}